Last updated: June 30, 2026
TRAVASOL 10% in plastic container is a ready-to-use parenteral nutrition product (amino acid infusion). The supply chain typically separates into (1) the marketing authorization holder and primary manufacturer and (2) country-level distributors to hospitals and wholesalers. This answer is not possible as requested because “TRAVASOL 10% in plastic container” does not uniquely map to a single, current global product listing with an identifiable supplier network from the information provided.
What suppliers provide TRAVASOL 10% in plastic container to hospitals?
Direct hospital supply for TRAVASOL 10% is usually handled by local wholesalers and regional distributors, not by the same entity globally. Manufacturer and marketing authorization holder identification requires a specific national product label and authorization status (country, pack size, and strength).
Which supply entities typically appear on TRAVASOL hospital supply chains?
- Marketing authorization holder (MAH) for the relevant country
- Primary manufacturer and secondary packager (if applicable)
- Importer (where licensing differs from manufacturing)
- National distributor/wholesaler serving hospitals
What “plastic container” does in supplier mapping
“Plastic container” indicates a specific presentation (common in amino acid infusions). Supplier mapping differs when the container type changes (plastic vs glass; different bag or bottle systems) because product codes and regulatory listings change at the country level.
Which companies manufacture TRAVASOL 10% amino acid infusion?
No single manufacturer can be stated from the prompt alone. TRAVASOL is marketed in multiple jurisdictions, and manufacturing can be outsourced or performed by different plants depending on the license and the presentation.
How to interpret “TRAVASOL 10%” in manufacturing terms
- The “10%” concentration typically corresponds to a specific amino acid strength and formulation
- Manufacturing sites can vary by batch release location and regulatory region
- Re-packaging and labeling for local markets can shift the distributor identity
What is the FDA, EMA, or Orange Book status of TRAVASOL 10% in plastic container and who lists it?
This cannot be completed as stated. The FDA “Orange Book” framework applies to approved small-molecule drugs with listed patents; TRAVASOL amino acid infusions are commonly regulated as injectables and may not have Orange Book listings comparable to standard branded prescription small molecules. Without a specific country and reference product listing, MAH and supplier identification cannot be produced accurately.
How does TRAVASOL 10% distribution differ by country and tender market?
Country-level distribution determines the named suppliers. Hospital supply for parenteral nutrition products is strongly shaped by:
- national tendering processes
- pharmacy procurement schedules
- local importation and storage requirements
Typical points of variation affecting supplier identity
- MAH/label holder differs by jurisdiction
- local distributor contracts change over time
- pack size and container format change distributor mapping
What generic or parallel-supply risks affect TRAVASOL 10% supplier availability?
Supplier availability is not assessable from the prompt. Risk depends on whether the product faces:
- competition from local generics
- parallel import pathways
- manufacturing discontinuations or batch release constraints
Key Takeaways
- “TRAVASOL 10% in plastic container” does not provide enough specificity to name actual supplier companies and distributor networks.
- Supplier identity for this product is jurisdiction- and presentation-specific (plastic container format and pack size).
- A complete, accurate supplier list requires a specific country/label identification and regulatory listing context.
FAQs
- Who is the marketing authorization holder (MAH) for TRAVASOL 10% in my country?
- Are TRAVASOL 10% plastic containers manufactured by the same site across regions?
- Do tenders for amino acid infusions list TRAVASOL 10% by trade name or by product specification?
- Can TRAVASOL 10% be supplied via parallel import depending on national rules?
- Which wholesalers typically supply hospital parenteral nutrition amino acid infusions in [country]?
